Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-014205
Filing Date
2021-03-18
Accepted
2021-03-18 17:25:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A acet-defa14a_20210427.htm DEFA14A 32433
2 GRAPHIC gpk4ikhwawvu000002.jpg GRAPHIC 319943
3 GRAPHIC gpk4ikhwawvu000001.jpg GRAPHIC 397400
  Complete submission text file 0001564590-21-014205.txt   1021185
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38359 | Film No.: 21755506
SIC: 2834 Pharmaceutical Preparations